Product Name | MF | CAS | Details |
---|
N-Acetyl AMPA | C3H8NO4P | 57637-97-5 | Details |
O-Desmethylvenlafaxine | C16H25NO2 | 93413-62-8 | Details |
N-Acetyl-D-alanine-2,3,3,3-d4 | C5H5D4NO3 | 2708343-30-8 | Details |
Acetyltributyl Citrate | C20H34O8 | 77-90-7 | Details |
O-DesmethylApixabanSulphateNa | C24H23N5O7S | 1118765-14-2 | Details |
O-Desmethyl Adapalene-13C6 | C27H26O3 | Details |
N-Acetyl-S-benzyl-[13C6]-L-cysteine | Details |
O,O-Dimethylphosphorodithioic acid ammonium salt | C2H10NO2PS2 | 1066-97-3 | Details |
O-Desmethyl Dacomitinib | Details |
O,O-Diethyl thiophosphate,potassium salt | C4H10KO3PS | 5871-17-0 | Details |
N-Isovaleryl-d9-glycine | C7H13NO3 | 1330037-21-2 | Details |
N-Isobutyryl-d7-glycine | (CD3)2CDCONHCH2COOH | 1330037-23-4 | Details |
O-DesmethylApixaban | C24H23N5O4 | 503612-76-8 | Details |
N-Acetyl-D-Glucosamine | C8H15NO6 | 7512-17-6 | Details |
N-Acetyl-5-hydroxytryptamine | C12H14N2O2 | 1210-83-9 | Details |
Deterenol acetate 100 μg/ml Methanol | C13H21NO4 | 1644449-83-1 | Details |
O-Desmethyl Mebeverine Acid D5 | C15H23NO3 | 586357-02-0 | Details |
C15H23NO2 | 26218-04-2 | Details |
4.4′-DDE in Methanol | C14H8Cl4 | 72-55-9 | Details |
Aildenafil-propoxyphenyl | C24H34N6O4S | 1391053-82-9 | Details |
C17881500 O,O,S-Trimethyldithiophosphate | C3H9O2PS2 | 2953-29-9 | Details |
Omega-3 Free Fatty Acids | Details |
N-Acetylprocainamide | C15H23N3O2 | 32795-44-1 | Details |
1-Oleate-2-Palmitate-3-Linoleate-Glycerol | C55H100O6 | 2534-97-6 | Details |
Anastrozole-[13C4] | C17H19N5 | 120511-73-1 | Details |
O,O,S-Trimethylthiophosphate in Acetonitrile | C3H9O3PS | 152-20-5 | Details |
N-acetyl-Cys1-calcitonin | Details |
N-Isopropyl-N`-phenyl-p-phenylenediamine (IPPD) | C15H18N2 | 101-72-4 | Details |
oxy-Chlordene in Cyclohexane | C10H6Cl6O | 6058-23-7 | Details |
O-Deethyl Reboxetine HCL | Details |
PB-22 N-(5-hydroxypentyl) metabolite-[d6] | C23H22N2O3 | 1884343-30-9 | Details |
PCB20 in Cyclohexane | C12H7Cl3 | 38444-84-7 | Details |
N-Acetyl-5-hydroxytryptamine-[d4] | C12H14N2O2 | 66521-40-2 | Details |
(R)-Lotaustralin | C11H19NO6 | 534-67-8 | Details |
R-Ofloxacin | C18H20FN3O4 | 100986-86-5 | Details |
rac-Adrenaline | Details |
rac-Anabasine-d4 DiHCl | C10H10D4N2 | 1020719-08-7 | Details |
rac-β-Tocopherol | C28H48O2 | 148-03-8 | Details |
Rac-Carbidopa-13C-d3 | Details |
R-(+)-Pulegone-RM | C10H16O | 89-82-7 | Details |
rac-Anatabine-d4 HCl | C10H8D4N2 | 1020719-11-2 | Details |
rU Phosphoramidite | C45H61N4O9PSi | 118362-03-1 | Details |
Rac-Bepotastine-d6 | C21H25ClN2O3 | Details |
R-(+)-Carvedilol-d4 | Details |
rac-Ambrisentan-d5 | C22H22N2O4 | 1392210-85-3 | Details |
rac-Apomorphine-13C-d3 HCl | C17H18ClNO2 | Details |
rac-N-Desmethyl Bedaquiline-d6 (Mixture of Diastereomers) | C31H29BrN2O2 | 2271264-46-9 | Details |
R2A Reference Medium (RRM) | Details |
rac-Aprepitant-d4 | C23H21F7N4O3 | Details |
rac-Cevimeline-d4 HCl (Mixture of Diastereomers) | C10H18ClNOS | 1286024-71-2 | Details |
rac-Cinacalcet-d3 HCl | C22H23ClF3N | 1185097-33-9 | Details |
S-Benzyl-L-cysteine | C10H13NO2S | 3054-01-1 | Details |
T-2 Toxin in Acetonitrile | C24H34O9 | 21259-20-1 | Details |
S-Methoprene 100 μg/ml Acetonitrile | C19H34O3 | 65733-16-6 | Details |
S-Phenyl-DL-cysteine-3,3-d2 | C9H11NO2S | 5437-52-5 | Details |
Esfenvalerate in Acetonitrile | C25H22ClNO3 | 66230-04-4 | Details |
Ademetionine disulfate tosylate | C22H34N6O16S4 | 97540-22-2 | Details |
S-Benzyl-DL-cysteine-2,3,3-d3 | C10H10D3NO2S | 51494-04-3 | Details |
S,S-Reboxetine-[d5] Phenol B metabolite formate salt | Details |
(S)-Mephenytoin | C12H14N2O2 | 70989-04-7 | Details |
S-Metolachlor Metabolite CGA 50720 100 μg/ml Acetonitrile | C11H13NO3 | 152019-74-4 | Details |
Ginsenoside Compound K(P) | C36H62O8 | 39262-14-1 | Details |
Chloroparaffin C10-C13, 51,5% Cl | 85535-84-8 | Details |
S,S-Reboxetine-[d5] Phenol A metabolite formiate salt | C19H23NO4 | 252570-35-7 | Details |
SN 38 glucuronide-[13C6] | C28H28N2O11 | 121080-63-5 | Details |
QCA-methylester-D3 | Details |
1000 ppm Carbon for TOC made from KHP H2O | Details |
Details |
USP 232 Parenteral Elemental Impurities HNO3 | Details |
U-[13C17]-Aflatoxin G1 in Acetonitrile | C17H12O7 | 1217444-07-9 | Details |
C7H6O4 | 1353867-99-8 | Details |
Details |
U-[13C17]-Aflatoxin G2 in Acetonitrile | C17H14O7 | 1217462-49-1 | Details |
U-[13C34]-Fumonisin B1 in Acetonitrile:Water=1:1 | C34H59NO15 | 1217458-62-2 | Details |
Triphenyl phosphate in Acetonitrile | C18H15O4P | 115-86-6 | Details |
U-[13C34]-Fumonisin B2 in Acetonitrile/Water(1:1) | C34H59NO14 | 1217481-36-1 | Details |
XA12710020AL(Z)-Dimethomorph 100μg/mLin Aceto | C21H22ClNO4 | 113210-98-3 | Details |
α-p-hydroxyphenylglycine | C8H9NO3 | 22818-40-2 | Details |
α-Artemether | C16H26O5 | 71939-51-0 | Details |
α,α,α`-Tris(4-hydroxyphenyl)-1-ethyl-4-isopropylbenzene | C29H28O3 | 110726-28-8 | Details |
LSD-GLA-S | C33H47N3O10 | 1011457-16-1 | Details |
alpha,alpha,alpha-Trifluorotoluene in Methanol | C7H5F3 | 98-08-8 | Details |
α-Chaconine-RM | C45H73NO14 | 20562-03-2 | Details |
LSD-IDUA-S | C30H39N3O10 | 1603827-86-6 | Details |
Alphacyclodextrin | C36H60O30 | 10016-20-3 | Details |
LSD-GLA-IS | C27H37N3O5 | 1447799-45-2 | Details |
(Z)-Pyribencarb | Details |
α-Hederin-RM | C41H66O12 | 27013-91-8 | Details |
Details |
Factor Xa | C217H342N68O60S3 | 9002-05-5 | Details |
L11890500CY zeta-Cypermethrin 10μg/mLin Cyclo | C22H19Cl2NO3 | 1315501-18-8 | Details |
N-Acetylneuraminic acid | C11H19NO9 | 131-48-6 | Details |
Alpha-Endosulfan in Iso-octane | C9H6Cl6O3S | 959-98-8 | Details |
o-DTPD-quinone | Details |
LSD-IDUA-IS | C24H31N3O4 | 1637653-66-7 | Details |
Details |
Uniconazole-P in Cyclohexane | C15H18ClN3O | 83657-17-4 | Details |
Details |
Zearalanone | C18H24O5 | 5975-78-0 | Details |
AF38469 | C15H11F3N2O3 | 1531634-31-7 | Details |
Product Total: Product Page: | ||||
21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 |